The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II/III, multicenter, open-label, 3-arm study of gilteritinib, gilteritinib plus azacitidine, or azacitidine alone in the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia (AML) patients ineligible for intensive induction chemotherapy.
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; ARIAD; BiolineRx; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Teva (Inst)
 
Jessica Altman
Consulting or Advisory Role - American Society of Hemotology; Bristol-Myers Squibb; Janssen; Janssen; National Comprehensive Cancer Network; National Comprehensive Cancer Network; National Comprehensive Cancer Network; Syros Pharmaceuticals
 
Ellen K. Ritchie
Consulting or Advisory Role - Celgene; Incyte; Novartis; Pfizer
Speakers' Bureau - ARIAD; Celgene; Incyte; Novartis
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); NS Pharma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
Richard A. Larson
Consulting or Advisory Role - Amgen; ARIAD; Bristol-Myers Squibb; Celgene; CVS Caremark; Jazz Pharmaceuticals; Novartis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Celgene (Inst); Daiichi Sankyo (Inst); ERYTECH Pharma (Inst)
 
David Claxton
Consulting or Advisory Role - PPD; Synapse
Research Funding - Ambit BioSciences; Astellas Pharma; Astex Pharmaceuticals; Celgene; Cyclacel; MedImmune; Merck; Novartis
 
Mark D. Minden
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - University Health Network
 
Alec Goldenberg
Patents, Royalties, Other Intellectual Property - Advanced Biopsy Technologies
 
Tomoki Naoe
Stock and Other Ownership Interests - Amgen Astellas BioPharma
Honoraria - Alexion Pharmaceuticals; Amgen Astellas BioPharma; Astellas Pharma; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Nippon Boehringer Ingelheim; Otsuka; Sysmex
Consulting or Advisory Role - Fujifilm (Inst)
Research Funding - Astellas Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Nippon Boehringer Ingelheim (Inst); Otsuka (Inst); Pfizer (Inst); Sysmex (Inst); Toyama Chemical Co (Inst)
Patents, Royalties, Other Intellectual Property - Chugai Pharma; Fujifilm; Kyowa Hakko Kirin
 
Sung-Soo Yoon
No Relationships to Disclose
 
Philippe H. Rousselot
No Relationships to Disclose
 
Carsten Mueller-Tidow
No Relationships to Disclose
 
Teresa Bernal del Castillo
No Relationships to Disclose
 
Violaine Havelange
No Relationships to Disclose
 
Fabio Ciceri
No Relationships to Disclose
 
Wanda Knopinska-Posluszny
No Relationships to Disclose
 
Shufang Liu
Employment - Astellas Pharma
Stock and Other Ownership Interests - Abbvie
 
Archita Shrivastava
Employment - Astellas Pharma
 
Angela Joubert James
Employment - Astellas Pharma
Stock and Other Ownership Interests - Celgene
Patents, Royalties, Other Intellectual Property - Celgene
 
Elizabeth Shima Rich
Employment - Astellas Pharma
 
Erkut Bahceci
Employment - Astellas Pharma